217 related articles for article (PubMed ID: 24801382)
21. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
22. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
Lin PT; Wang SH; Chi CC
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
[TBL] [Abstract][Full Text] [Related]
23. Pentoxifylline for intermittent claudication.
Salhiyyah K; Senanayake E; Abdel-Hadi M; Booth A; Michaels JA
Cochrane Database Syst Rev; 2012 Jan; 1():CD005262. PubMed ID: 22258961
[TBL] [Abstract][Full Text] [Related]
24. Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Andras A; Sala Tenna A; Stewart M
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD002001. PubMed ID: 28737834
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hypertension in peripheral arterial disease.
Lane DA; Lip GY
Cochrane Database Syst Rev; 2013 Dec; (12):CD003075. PubMed ID: 24307487
[TBL] [Abstract][Full Text] [Related]
26. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Jones LE
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
[TBL] [Abstract][Full Text] [Related]
27. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
Chen YC; Chi CC; Chan FC; Wen YW
Cochrane Database Syst Rev; 2013 Jul; (7):CD009894. PubMed ID: 23836382
[TBL] [Abstract][Full Text] [Related]
28. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Andras A; Sala Tenna A; Crawford F
Cochrane Database Syst Rev; 2012 Oct; 10():CD002001. PubMed ID: 23076894
[TBL] [Abstract][Full Text] [Related]
29. Modes of exercise training for intermittent claudication.
Jansen SC; Abaraogu UO; Lauret GJ; Fakhry F; Fokkenrood HJ; Teijink JA
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009638. PubMed ID: 32829481
[TBL] [Abstract][Full Text] [Related]
30. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Robertson L; Roche A
Cochrane Database Syst Rev; 2013 Dec; (12):CD010525. PubMed ID: 24343728
[TBL] [Abstract][Full Text] [Related]
31. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
Zee AA; van Lieshout K; van der Heide M; Janssen L; Janzing HM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006681. PubMed ID: 28780771
[TBL] [Abstract][Full Text] [Related]
32. Modes of exercise training for intermittent claudication.
Lauret GJ; Fakhry F; Fokkenrood HJ; Hunink MG; Teijink JA; Spronk S
Cochrane Database Syst Rev; 2014 Jul; (7):CD009638. PubMed ID: 24993079
[TBL] [Abstract][Full Text] [Related]
33. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
35. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
[TBL] [Abstract][Full Text] [Related]
36. Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.
Hageman D; Fokkenrood HJ; Gommans LN; van den Houten MM; Teijink JA
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005263. PubMed ID: 29627967
[TBL] [Abstract][Full Text] [Related]
37. Beta blockers for peripheral arterial disease.
Paravastu SC; Mendonca DA; Da Silva A
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD005508. PubMed ID: 24027118
[TBL] [Abstract][Full Text] [Related]
38. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
[TBL] [Abstract][Full Text] [Related]
39. Angioplasty versus bare metal stenting for superficial femoral artery lesions.
Chowdhury MM; McLain AD; Twine CP
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006767. PubMed ID: 24959692
[TBL] [Abstract][Full Text] [Related]
40. Interventions for preventing thrombosis in solid organ transplant recipients.
Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
